Aurora Cannabis (TSE:ACB) Second Quarter 2025 Results
Key Financial Results
- Revenue: CA$81.1m (up 28% from 2Q 2024).
- Net income: CA$2.60m (up 40% from 2Q 2024).
- Profit margin: 3.2% (up from 2.9% in 2Q 2024).
- EPS: CA$0.05 (up from CA$0.048 in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Aurora Cannabis Earnings Insights
Looking ahead, revenue is forecast to grow 9.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Canada.
Performance of the Canadian Pharmaceuticals industry.
The company’s shares are down 9.2% from a week ago.
Risk Analysis
Before we wrap up, we’ve discovered 1 warning sign for Aurora Cannabis that you should be aware of.
New: Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s…
